CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-17 | Sukhtian Ghiath M. Director | Option exercise | +3,458,571 | $2.51 | $8.7M | 9,266,645 |
| 2025-01-17 | Sukhtian Ghiath M. Director | Returned to the company · Warrants (right to buy) | −3,458,571 | 0 | ||
| 2025-01-17 | Sukhtian Ghiath M. Director | Grant or award · Warrants (right to buy) | +3,458,571 | 3,458,571 | ||
| 2025-01-17 | Sukhtian Ghiath M. Director | Option exercise · Warrants (right to buy) | −3,458,571 | 0 | ||
| 2025-01-17 | Sukhtian Ghiath M. Director | Grant or award · Warrants (right to buy) | +3,458,571 | 3,458,571 | ||
| 2025-01-17 | Sukhtian Ghiath M. Director | Grant or award · Warrants (right to buy) | +3,458,571 | 3,458,571 | ||
| 2024-10-03 | Haller Julia A Director | Grant or award · Stock Option (Right to Buy) | +12,082 | 12,082 | ||
| 2024-10-03 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +10,984 | 10,984 | ||
| 2024-10-03 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +12,082 | 12,082 | ||
| 2024-10-03 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +19,771 | 19,771 | ||
| 2024-10-03 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +19,771 | 19,771 | ||
| 2024-10-03 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +18,672 | 18,672 | ||
| 2024-10-01 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +56,636 | 56,636 | ||
| 2024-10-01 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +71,169 | 71,169 | ||
| 2024-10-01 | Haller Julia A Director | Grant or award · Stock Option (Right to Buy) | +56,636 | 56,636 | ||
| 2024-10-01 | Haller Julia A Director | Grant or award · Stock Option (Right to Buy) | +47,232 | 47,232 | ||
| 2024-10-01 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +56,636 | 56,636 | ||
| 2024-10-01 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +23,509 | 23,509 | ||
| 2024-10-01 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +56,636 | 56,636 | ||
| 2024-10-01 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +29,493 | 29,493 |
Page 3 of 8 · 142 trades